Evidence mapPaperPMID 39903429Full record

ReviewJournal of molecular neuroscience : MN2025

Neuronal Injury after Ischemic Stroke: Mechanisms of Crosstalk Involving Necroptosis.

Xuanning Zhang, Hongyu Li, Yaowei Zhao, Tingting Zhao, Zhihao Wang, Qiang Tang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular neuroscience : MN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuanning ZhangHeilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Hongyu LiHeilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Yaowei ZhaoHeilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Tingting ZhaoHeilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Zhihao WangHeilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Qiang TangHeilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China. tangqiang1963@163.com.

Funding

Heilongjiang Provincial Department of Human Resources and Social Security LBH-Z20201
6 · The paper itself

Abstract

Ischemic stroke is a leading cause of disability and death worldwide, largely due to its increasing incidence associated with an aging population. This condition results from arterial obstruction, significantly affecting patients' quality of life and imposing a substantial economic burden on healthcare systems. While current treatments primarily focus on the rapid restoration of blood flow through thrombolytic therapy or surgical interventions, a limited understanding of neuronal injury mechanisms hampers the development of more effective treatments.This article explores the interplay among various cell death pathways-necroptosis, apoptosis, autophagy, ferroptosis, and pyroptosis-in the context of ischemic stroke to identify novel therapeutic targets. Each mode of cell death displays unique characteristics and roles post-stroke, and the activation of these pathways may vary across different animal models, complicating the translation of therapeutic strategies to clinical settings. Notably, the interaction between apoptosis and necroptosis is highlighted; inhibiting apoptosis might heighten the risk of necroptosis. Therefore, a balanced regulation of these pathways could promote enhanced neuronal survival.Additionally, we introduce PANoptosis, a form of cell death that encompasses pyroptosis, apoptosis, and necroptosis, emphasizing the complexity and potential therapeutic implications of these interactions. In summary, understanding the relationships among these cell death mechanisms in ischemic stroke is vital for developing new neuroprotective agents. Future research should aim for combinatorial interventions targeting multiple pathways to optimize treatment strategies and improve patient outcomes.

Indexed as

Ischemic StrokeNecroptosisNeuronsAnimalsApoptosisAutophagyHumansPyroptosisApoptosisCell Death PathwaysIschemic StrokeNecroptosisPANoptosis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.